7. Bibliografía

-World Health Organization. Factsheet sexually transmitted infections (STIs) [Internet]. WHO; 2019; updated 28 Feb 2019; cited 8 Apr 2019. Available from: https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis)

-Ebrahim SH, Peterman TA, Zaidi AA, Kamb ML. Mortality related to sexually transmitted diseases in US women, 1973 through 1992. Am J Public Health. 1997; 87:938-44.

-McElligott KA. Mortality from sexually transmitted diseases in reproductive-aged women: United States, 1999-2010. Am J Public Health. 2014; 104:e101-5.

-Soriano V, Romero JD. Rebound in Sexually Transmitted Infections Following the Success of Antiretrovirals for HIV/AIDS. AIDS Rev. 2018; 20:187-204.

-Four curable sexually transmitted infections still affect millions worldwide. Publicado en WHO Bulletin june 6th 2019, disponible en https://www.who.int/reproductivehealth/topics/rtis/en/

-World Health Organization. Global health sector strategy on sexually transmitted infections 2016–2021: toward ending STIs. Geneva: WHO; 2016.

-Unemo M, Bradshaw CS, Hocking JS, de Vries HJC, Francis SC, Mabey D, Marrazzo JM, Sonder GJB, Schwebke JR, Hoornenborg E, Peeling RW, Philip SS, Low N, Fairley CK. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017; 17:e235-79.

-European Centre for Disease Control. Developing a national strategy for the prevention and control of sexually transmitted infections. Stockhol: ECDC; 2019. En:

https://www.ecdc.europa.eu.

-Khaw C, Richardson D, Matthews G, Read T. Looking at the positives: proactive management of STIs in people with HIV. AIDS Res Ther. 2018; 15:285. CDC. Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR Recomm Rep 2015; 64(No. RR-3):1-140.

-Rinaldi G, Kiadaliri AA, Haghparast-Bidgoli H. Cost effectiveness of HIV and sexual reproductive health interventions targeting sex workers: a systematic review. Cost Eff Resour Alloc. 2018; 16:63.

-Celentano DD, Nelson KE, Suprasert S, Eiumtrakul S, Kuntolbutra S, Beyrer C, Zenilman J, Wright NH, Theetranont C. Epidemiologic risk factors for incident sexually transmitted diseases in young Thai men. Sex Transm Dis. 1996; 23:198-205.

-ECDC. Systematic review on communicable diseases in prison settings. Estocolmo: Nov, 2017. Available from: https://ecdc.europa.eu/sites/portal/files/documents/Systematic-review-on-communicable-diseases-in-prison-settings-final-report.pdf

-Chacowry Pala K, Baggio S, Tran NT, Girardin F, Wolff H, Gétaz L. Blood-borne and sexually transmitted infections: a cross-sectional study in a Swiss prison. BMC Infect Dis. 2018; 18:539.

-Shapiro RA, Makoroff KL. Sexually transmitted diseases in sexually abused girls and adolescents. Curr Opin Obstet Gynecol. 2006; 18:492-7.

-López de Munain J. Epidemiology and current control of sexually transmitted infections. The role of STI clinics. Enferm Infecc Microbiol Clin. 2019; 37:45-49.

-Catchpole MA. The role of epidemiology and surveillance systems in the control of sexually transmitted diseases. Genitourin Med. 1996; 72:321-9.

-Hogben M, Collins D, Hoots B, OʼConnor K. Partner Services in Sexually Transmitted Disease Prevention Programs: A Review. Sex Transm Dis. 2016; 43(2 Suppl 1):S53-62.

-Lewis FM, Dittus P, Salmon ME, Nsuami MJ. School-Based Sexually Transmitted Disease Screening: Review and Programmatic Guidance. Sex Transm Dis. 2016; 43(2 Suppl 1):S18-27.

-Mason-Jones AJ, Sinclair D, Mathews C, Kagee A, Hillman A, Lombard C. School-based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents. Cochrane Database Syst Rev. 2016; 11:CD006417.

-Yang J, Dhital S, Naderer T. Efficacy and Safety of Injectable and Oral Antibiotics in Treating Gonorrhea: A Systematic Review and Network Meta-Analysis. J Clin Med. 2019; 8. pii: E2182. doi: 10.3390/jcm8122182.

-Groves MJ. Genital Herpes: A Review. Am Fam Physician. 2016; 93:928-34.

-Hu K, He S, Xiao J, Li M, Luo S, Zhang M, Hu Q. Interaction between herpesvirus entry mediator and HSV-2 glycoproteins mediates HIV-1 entry of HSV-2-infected epithelial cells. J Gen Virol. 2017; 98:2351-2361.

-Milpied B, Janier M, Timsit J, Spenatto N, Caumes E, Chosidow O, Sentilhes L, Senat MV; Groupe infectiologie dermatologique et infections sexuellement transmissibles (GrIDIST) de la Société française de dermatologie et du Collège national des gynécologues obstétriciens français (CNGOF). Recommandations diagnostiques et therapeutiques pour les maladies sexuellement transmissibles: herpes genital. Ann Dermatol Venereol. 2018. pii: S0151-9638(18)30717-8.

-Sénat MV, Anselem O, Picone O, Renesme L, Sananès N, Vauloup-Fellous C, Sellier Y, Laplace JP, Sentilhes L. Prevention and management of genital herpes simplex infection during pregnancy and delivery: Guidelines from the French College of Gynaecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol. 2018; 224:93-101.

-Ribeiro AL, Caodaglio AS, Sichero L. Regulation of HPV transcription. Clinics (Sao Paulo). 2018; 73(suppl 1):e486s.

-Lazcano-Ponce E, Sudenga SL, Torres BN, Stoler M, León-Maldonado L, Allen-Leigh B, Posso H, Quiterio M, Hernández-Nevarez MDP, Salmerón J, Giuliano AR. Incidence of external genital lesions related to human papillomavirus among Mexican men. A cohort study. Salud Publica Mex. 2018; 60:633-64.

-Park IU, Introcaso C, Dunne EF. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis. 2015; 61 Suppl 8:S849-55.

-Garland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, Ferenczy A, Ferris DG, Giuliano AR, Hernandez-Avila M, Huh WK, Iversen OE, Kjaer SK, Kurman RJ, Luna J, Monsonego J, Muñoz N, Paavonen J, Pitisuttihum P, Ronnett BM, Steben M, Stoler MH, Wheeler CM, Wiley DJ, Perez G, Saah AJ, Luxembourg A, Li S, DiNubile MJ, Wagner M, Velicer C. Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age. Obstet Gynecol. 2018; 132:261-270.

-Casanova-Seuma JM, Garcia de la Fuente MR, Fernández-Armenteros JM, Aguayo-Ortiz R, Sanmartín-Novell V. Lesiones genitales premalignas y malignas. FMC: Formación Médica Continuada en Atención Primaria 2018; 25: 270-280.

-Casanova-Seuma JM, Fernández-Armenteros JM, García-de la Fuente MR, Llarden García M, Aguayo-Ortiz M. Tratamiento de las verrugas vulgares y de los condilomas acuminados. FMC. 2017; 24:405-13.

-Buck H Jr. Warts (genital). BMJ Clin Evid. 2010;2010. pii: 1602.

-Tamer E, Çakmak SK, İlhan MN, Artüz F. Demographic characteristics and risk factors in Turkish patients with anogenital warts. J Infect Public Health. 2016; 9:661-6.

-Grillo-Ardila CF, Angel-Müller E, Salazar-Díaz LC, Gaitán HG, Ruiz- Parra AI, Lethaby A. Imiquimod for anogenital warts in non-immunocompromised adults. Cochrane Database Syst Rev. 2014; (11):CD010389.

-Karnes JB, Usatine RP. Management of external genital warts. Am Fam Physician. 2014; 90:312-8.

-Thurgar E, Barton S, Karner C, Edwards SJ. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation. Health Technol Assess. 2016; 20:1-486.

-Taner ZM, Taskiran C, Onan AM, Gursoy R, Himmetoglu O. Therapeutic value of trichloroacetic acid in the treatment of isolated genital warts on the external female genitalia. J Reprod Med. 2007; 52:521-5.

-Anogenital warts. En: Sexually transmited diseases treatment guidelines. MMWR. 2015; 64:86-93.

-Human papillomavirus vaccines: WHO position paper, October 2014-Recommendations. Vaccine. 2015; 33:4383-4.

-Gameiro A, Alves J, Santo I, Azevedo J. Condilomas Anogenitais numa Consulta de Doenças Sexualmente Transmissíveis: Centro de Saúde da Lapa – Lisboa, 2008 a 2014. Acta Med Port. 2016; 29:101-6.

-Mann LM, Llata E, Flagg EW, Hong J, Asbel L, Carlos-Henderson J, Kerani RP, Kohn R, Pathela P, Schumacher C, Torrone EA. Trends of Anogenital Warts Among Sexually Transmitted Disease Clinic Patients -Sexually Transmitted Disease Surveillance Network, United States, 2010-2016. J Infect Dis. 2018. doi: 10.1093/infdis/jiy684.

-Steben M, Tan Thompson M, Rodier C, Mallette N, Racovitan V, DeAngelis F, Stutz M, Rampakakis E. A Review of the Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: 10 Years of Clinical Experience in Canada. J Obstet Gynaecol Can. 2018; 40:1635-1645.

-Rossi C, Vanhomwegen C, Laurent F. Vaccination contre le papillomavirus humain (HPV) chez les garçons et les hommes: actualités et recommandations. Rev Med Brux. 2018; 39:352-358.

-Zichichi L, Maniscalco M. The challenges of a neglected STI: Molluscum contagiosum. G Ital Dermatol Venereol. 2012; 147:447-53.

-Borrego P, Goncalves MF, Gomes P, Araújo L, Moranguinho I, Figueiredo IB, Barahona I, Rocha J, Mendonça C, Cruz MC, Barreto J, Taveira N. Assessment of the Cavidi ExaVir load assay for monitoring plasma viral load in HIV-2-infected patients. J Clin Microbiol 2017; 55:2367-2379

-ONUSIDA. El Sida en Cifras 2015. Disponible en www. unaids.org/es/resources/documents/2015/AIDS by the numbers 2015.

-Michael S, Robert S, Howard M, Joel D, Peng Thim F, Robert A, Andrew S. Pneumocystis carinii Pneumonia and Mucosal Candidiasis in Previously Healthy Homosexual Men —Evidence of a New Acquired Cellular Immunodeficiency. N Engl J Med 1981; 305:1425-1431

-Vilaseca J, Arnau JM, Bacardi R, Mieras C, Serrano A, Navarro C. Kaposi’s sarcoma and toxoplasma gondii brain abscess in a Spanish homosexual. Lancet 1982; 1:572

-Smith DK, Herbst JH, Zhang X, Rose CE. Condom effectiveness for HIV prevention by consistency of use among men who have sex with men in the United States. J Acquir Immune Defic Syndr 2015; 68:37-344.

-Pretty LA, Anderson GS, Sweet DJ. Human bites and the risk of human immunodeficiency virus transmission. Am J Forensic Med Pathol 1999; 20:232-239

-Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk: a systematic review. AIDS 2014; 28:1509-1519

-Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kakia A, Odoyo J, Mucunguzi A, Nakku-Joloba E, Twesigye R, Ngure K, Apaka C, Tamooh H, Gabona F, Mujugira A, Panteleeff D, Thomas KK, Kidoguchi L, Krows M, Revall J, Morrison S, Haugen H, Emmanuel-Ogier M, Ondrejcek L, Coombs RW, Frenkel L, Hendrix C, Bumpus NN, Bangsberg D, Haberer JE, Stevens WS, Lingappa JR, Celum C; Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012; 367:399-410.

-Cain LE, Logan R, Robins JM, Sterne JA, Sabin C, Bansi L, Justice A, Goulet J, van Sighem A, de Wolf F, Bucher HC, von Wyl V, Esteve A, Casabona J, del Amo J, Moreno S, Seng R, Meyer L, Perez-Hoyos S, Muga R, Lodi S, Lanoy E, Costagliola D, Hernan MA; HIV-CAUSAL Collaboration. When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. Ann Intern Med 2011; 154:509-515

-Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, Hoy JF, ugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. JAMA 2016; 316:191-210.

-Meulbroek M, Dalmau-Bueno A, Pujol F, Pérez F, Taboada H, Carrillo A. Cohort for MSM as a Useful Tool to Assure Cost Effectiveness during the Implementation of PrEP. 15th European AIDS Conference, Barcelona 21-24 Octubre 2015. 2015.

-Navarrete-Dechent C, Ortega R, Fich F, Concha M. Dermatologic manifestations associated with HIV/AIDS. Rev Chilena Infectol. 2015; 32 Suppl 1:S57-71.

-Greenspan JS, Greenspan D, Webster-Cyriaque J. Hairy leukoplakia; lessons learned: 30-plus years. Oral Dis. 2016; 22 Suppl 1:120-7.

-Casanova JM, Puig T, Rubio M. Hypertrichosis of the eyelashes in acquired immunodeficiency syndrome. Arch Dermatol. 1987; 123:1599-601.

-Shadyab AH, Crum-Cianflone NF. Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: a review of the literature. HIV Med. 2012; 13:319-32.

-Glaser P, Martins-Simoes P, Villain A, Barbier M, Tristan A, Bouchier C, Ma L, Bes M, Laurent F, Guillemot D, Wirth T, Vandenesch F. Demography and intercontinental spread of the USA300 community-acquired methicillin-resistant Staphylococcus aureus lineage. MBio. 2016; 7:e02183–215.

-Hidron AI, Moanna A, Rimland D. The rise and fall of methicil-lin-resistant Staphylococcus aureus infections in HIV patients. AIDS. 2011; 25:1001–1003.

-Patel PK, Erlandsen JE, Kirkpatrick WR, Berg DK, Westbrook SD, Louden C, Cornell JE, Thompson GR, Vallor AC, Wickes BL, Wiederhold NP, Redding SW, Patterson TF. The changing epidemiology of oropharyngeal candidiasis in patients with HIV/AIDS in the era of antiretroviral therapy. AIDS Res Treat. 2012;2012:262471.

-Patel P, Bush T, Mayer KH, Desai S, Henry K, Overton ET, Conley L, Hammer J, Brooks JT; SUN Study Investigators. Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the United States. Sex Transm Dis. 2012; 39:154–160.

-Lingappa JR, Celum C. Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection. Drugs. 2007; 67:155-74.

-Ozcan A, Senol M, Saglam H, Seyhan M, Durmaz R, Aktas E, Ozerol IH. Comparison of the Tzanck test and polymerase chain reaction in the diagnosis of cutaneous herpes simplex and varicella zoster virus infections. Int J Dermatol. 2007; 46:1177–1179.

-Levin MJ, Anderson JP, Seage GR 3rd, Williams PL. Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children. J Acquir Immune Defc Syndr. 2009; 50:182–191.

-Schulz D, Sarra GM, Koerner UB, Garweg JG. Evolution of HIV1-related conjunctival molluscum contagiosum under HAART: report of a bilaterally manifesting case and literature review. Graefes Arch Clin Exp Ophthalmol. 2004; 242:951-5.

-Dunic I, Vesic S, Jevtovic DJ. Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy. HIV Med. 2004; 5:50–54.

-Forrestel AK, Kovarik CL, Mosam A, Gupta D, Maurer TA, Micheletti RG. Difuse HIV-associated seborrheic dermatitis —a case series. Int J STD AIDS. 2016; 27:1342–1345.

-Morar N, Willis-Owen SA, Maurer T, Bunker CB. HIV-associated psoriasis: pathogenesis, clinical features, and management. Lancet Infect Dis. 2010; 10:470–478.

–Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens–Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J. 2002;8(1).

-Ripamonti D, Benatti SV, Di Filippo E, Ravasio V, Rizzi M. Drug reaction with eosinophilia and systemic symptoms associated with raltegravir use: case report and review of the literature. AIDS. 2014; 28:1077-9.

-Cesarman E, Damania B, Krown SE, Martin J, Bower M, Whitby D. Kaposi sarcoma. Nat Rev Dis Primers. 2019; 5:9.

-Hoffmann C, Sabranski M, Esser S. HIV-Associated Kaposi’s Sarcoma. Oncol Res Treat. 2017; 40:94-98.

-Lebbe C, Garbe C, Stratigos AJ, Harwood C, Peris K, Marmol VD, Malvehy J, Zalaudek I, Hoeller C, Dummer R, Forsea AM, Kandolf-Sekulovic L, Olah J, Arenberger P, Bylaite-Bucinskiene M, Vieira R, Middleton M, Levy A, Eggermont AM, Battistella M, Spano JP, Grob JJ, Pages C; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organisation for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of Kaposi’s sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC).Eur J Cancer. 2019; 114:117-127.

-Rodriguez O, Kovarik CL. Spectrum and progression of disease from condyloma to aggressive anogenital squamous cell carcinoma in 3 HIV-positive patients. JAAD Case Rep. 2016; 2:47–50.

-Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015; 64:300–304.

-Casanova-Seuma JM, Garcia de la Fuente MR, Fernández-Armenteros JM, Aguayo-Ortiz R, Sanmartín-Novell V. Lesiones genitales premalignas y malignas. FMC: Formación Médica Continuada en Atención Primaria 2018; 25: 270-280).

-Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1-137.

-Edwards SK, Bunker CB, Ziller F, van der Meijden WI. 2013 European guideline for the management of balanoposthitis. Int J STD AIDS. 2014; 25:615-26.

-Borelli S, Lautenschlager S. Differenzial diagnose und Management der Balanitis. Hautarzt. 2015; 66:6-11.

-WHO. “Estrategia mundial del sector de la salud contra las infecciones de transmisión sexual 2016–2021 Hacia el fin de las ITS”, en https://apps.who.int/iris/bitstream/handle/10665/250253/WHO-RHR-16.09-spa.pdf?sequence=1https://apps.who.int/iris/bitstream/handle/10665/250253/WHO-RHR-16.09-spa.pdf?sequence=1.

-Hein DC, Wagenlehner FME. Aktuelle Diagnostik und Therapie der sexuell übertragbaren Infektionen. Urologe A. 2018; 57:1436-1444.

-Schneede P, Weidner W. Gonokokken- und Chlamydieninfektionen der Harnröhre: Die neuen Urethritisleitlinien. Urologe A. 2014; 53:1444-51.

-Venter JME, Mahlangu PM, Müller EE, Lewis DA, Rebe K, Struthers H, McIntyre J, Kularatne RS. Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens. BMC Infect Dis. 2019;19:6.

-Jones J, Weiss K, Mermin J, Dietz P, Rosenberg ES, Gift TL, Chesson H, Sullivan PS, Lyles C, Bernstein KT, Jenness SM. Proportion of Incident HIV Cases among Men Who Have Sex with Men Attributable to Gonorrhea and Chlamydia: A Modeling Analysis. Sex Transm Dis. 2019. doi: 10.1097/OLQ.0000000000000980.

-Hooton TM, Barnes RC. Sexually transmitted diseases. Urethritis in men. Infect Dis Clin North Am. 1987;1:165-78.

-Kularatne RS, Niit R, Rowley J, Kufa-Chakezha T, Peters RPH, Taylor MM, Johnson LF, Korenromp EL. Adult gonorrhea, chlamydia and syphilis prevalence, incidence, treatment and syndromic case reporting in South Africa: Estimates using the Spectrum-STI model, 1990-2017. PLoS One. 2018; 13:e0205863.

-Götz HM, van Oeffelen LA, Hoebe CJPA, van Benthem BH. Regional differences in chlamydia and gonorrhoeae positivity rate among heterosexual STI clinic visitors in the Netherlands: contribution of client and regional characteristics as assessed by cross-sectional surveillance data. BMJ Open. 2019; 9:e022793.

-López-Corbeto E, González V, Lugo R, Rivaya B, Casabona J, Matas L; CT NG Study Group; Investigators of the CT NG Study Group. Pooling of urine samples for molecular detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium as a screening strategy among young adults in Catalonia. Enferm Infecc Microbiol Clin. 2019. pii: S0213-005X(19)30185-5.

-MSC, Ministerio de Sanidad y Consumo: Vigilancia epidemiológica de las infecciones de transmisión sexual en España, 2017, en https://www.mscbs.gob.es/ciudadanos/enfLesiones/enfTransmisibles/sida/vigilancia/Vigilancia_ITS_1995_2017_def.pdf.

–CEEISCAT, 2019. Vigilància epidemiològica de les infeccions de transmissió sexual a Catalunya. Sistema de notificació de malalties de declaració obligatòria i del sistema de notificació microbiològica. Informe anual 2018.

-Hook EW, Handsfield HH “Gonococcal infections in adult.” A: Holmes KG, Sparling PF, Stamm WE [et al.], editors. Sexually Transmitted Diseases. 4a ed. Nova York: The MCGraw-Hill Companies, Inc., 2007; p. 627-645.

-Suay-García B, Pérez-Gracia MT. Future Prospects for Neisseria gonorrhoeae Treatment. Antibiotics (Basel). 2018; 7. pii: E49. doi: 10.3390/antibiotics7020049.

–Lahra MM, Martin I, Demczuk W, Jennison AV, Lee KI, Nakayama SI, Lefebvre B, Longtin J, Ward A, Mulvey MR, Wi T, Ohnishi M, Whiley D. Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain. Emerg Infect Dis. 2018; 24. doi: 10.3201/eid2404.171873.

–Day MJ, Spiteri G, Jacobsson S, Woodford N, Amato-Gauci AJ, Cole MJ, Unemo M; Euro-GASP network. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016. BMC Infect Dis. 2018; 18:609.

-Day MJ, Spiteri G, Jacobsson S, Woodford N, Amato-Gauci AJ, Cole MJ, Unemo M; Euro-GASP network. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016. BMC Infect Dis. 2018; 18:609.

-Buder S, Dudareva S, Jansen K, Loenenbach A, Nikisins S, Sailer A, Guhl E, Kohl PK, Bremer V; GORENET study group. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance. BMC Infect Dis. 2018; 18:4.

-Guerrero-Torres MD, Menéndez MB, Guerras CS, Tello E, Ballesteros J, Clavo P, Puerta T, Vera M, Ayerdi O, Carrio JC, Mozo I, Del Romero J, Vázquez JA, Abad R. Epidemiology, molecular characterisation and antimicrobial susceptibility of Neisseria gonorrhoeae isolates in Madrid, Spain, in 2016. Epidemiol Infect. 2019; 147:e274.

-Cobo F, Cabezas-Fernández MT, Cabeza-Barrera MI. Antimicrobial susceptibility and typing of Neisseria gonorrhoeae strains from Southern Spain, 2012-2014. Enferm Infecc Microbiol Clin. 2016; 34:3-7.

-Davido B, Dinh A, Senard O, Calin R, Makhloufi S, Salomon J. Repurposing an old drug: aztreonam as a new treatment strategy for gonorrhoea. J Antimicrob Chemother. 2017; 72:1466-1468.

-Brittain C, Childs M, Duley L, Harding J, Hepburn T, Meakin G, Montgomery AA, Tan W, Ross JD. Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial. Trials. 2016; 17:558.

-Rondeau P, Valin N, Decré D, Girard PM, Lacombe K, Surgers L. Chlamydia trachomatis screening in urine among asymptomatic men attending an STI clinic in Paris: a cross-sectional study. BMC Infect Dis. 2019; 19:31.

-Bianchi S, Frati ER, Canuti M, Colzani D, Fasoli E, Amendola A, Tanzi E. Molecular epidemiology and genotyping of Chlamydia trachomatis infection in a cohort of young asymptomatic sexually active women (18-25 years) in Milan, Italy. J Prev Med Hyg. 2016; 57:E128-E134.

-Yuguero O, Casanova JM, Manonelles A, Godoy P. Detection of Chlamydia trachomatis infection in patients seen at a sexually transmitted infection clinic. Actas Dermosifiliogr. 2015; 106:235-8.

-Silva GARD, Motta HLSN, Souza EFA, Cardoso PANM, Pilotto JH, Eyer-Silva WA, Ribeiro LCP, Santos MSD, Azevedo MCVM, Pinto JFDC, Motta RN, Ferry FRA. Chlamydia trachomatis asymptomatic urethritis recurrence among males living with HIV-1. Rev Inst Med Trop Sao Paulo. 2018; 60:e65.

-Hamasuna R. Mycoplasma genitalium in male urethritis: diagnosis and treatment in Japan. Int J Urol. 2013; 20:676-84.

-Maduna LD, Laumen JG, Radebe O, Kock MM, Peters RP. Failure of syndromic management due to drug-resistant Mycoplasma genitalium infection in South Africa: a case report. Int J STD AIDS. 2019:956462418820745.

-Lillis RA, Martin DH, Nsuami MJ. Mycoplasma genitalium Infections in Women Attending a Sexually Transmitted Disease Clinic in New Orleans. Clin Infect Dis. 2018. doi: 10.1093/cid/ciy922.

-Magdaleno-Tapial J, Valenzuela-Oñate C, Giacaman-von der Weth MM, Ferrer-Guillén B, Martínez-Domenech Á, García-Legaz Martínez M, Ortiz-Salvador JM, Subiabre-Ferrer D, Hernández-Bel P. Haemophilus Species Isolated in Urethral Exudates as a Possible Causative Agent in Acute Urethritis: A Study of 38 Cases. Actas Dermosifiliogr. 2019; 110:38-42.

-Saxena A, Dawar R, Bora U. Haemophilus parainfluenzae urethritis through orogenital transmission. Indian J Sex Transm Dis AIDS. 2018; 39:127-129.

-Horner P, Boag F. Clinical Effectiveness Group. 2006 UK National guideline for the management of genital tract infection with Chlamydia trachomatis. Londres: British Association for Sexual Health and HIV (BASHH), 2006.

-ECDC, 2019. Developing a national strategy for the prevention and control of sexually transmitted infections; en https://www.ecdc.europa.eu/sites/default/files/documents/strategies-to-control-STIs.pdf).

-CEEISCAT, 2019; Vigilància epidemiològica de les infeccions de transmissió sexual a Catalunya. Informe anual 2018.

-Gillespie CW, Manhart LE, Lowens MS, Golden MR. Asymptomatic urethritis is common and is associated with characteristics that suggest sexually transmitted etiology. Sex Transm Dis. 2013; 40:271-4.

-Romano SS, Jensen JS, Lowens MS, Morgan JL, Chambers LC, Robinson TS, Totten PA, Soge OO, Golden MR, Manhart LE. Long duration of asymptomatic Mycoplasma genitalium infection after syndromic treatment for nongonococcal urethritis. Clin Infect Dis. 2018. doi: 10.1093/cid/ciy843.

-Fouts AC, Kraus SJ. Trichomonas vaginalis: Reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis. 1980; 141:137.

-Van Der Pol B, Kraft CS, Williams JA. Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol. 2006; 44:366.

-Mann JR, McDermott S, Gill T. Sexually transmitted infection is associated with increased risk of preterm birth in South Carolina women insured by Medicaid. J Matern Fetal Neonatal Med. 2010; 23:563-8.

-Sherry L, Kean R, McKloud E et al. Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole. Antimicrob Agents Chemother. 2017; 61. pii: e01065-17.

-Pericolini E, Perito S, Castagnoli A, Gabrielli E, Mencacci A, Blasi E, Vecchiarelli A, Wheeler RT. Epitope unmasking in vulvovaginal candidiasis is associated with hyphal growth and neutrophilic infiltration. PLoS One. 2018; 13:e0201436.

-Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016; 42:905-27.

-Borges KRA, Pimentel IV, Lucena LCLDS, Silva MACND, Monteiro SG, Monteiro CA, Nascimento MDDSB, Bezerra GFB. Adhesion and biofilm formation of Candida parapsilosis isolated from vaginal secretions to copper intrauterine devices. Rev Inst Med Trop Sao Paulo. 2018; 60:e59.

-Makanjuola O, Bongomin F, Fayemiwo SA. An Update on the Roles of Non-albicans Candida Species in Vulvovaginitis. J Fungi (Basel). 2018; 4. pii: E121.

-Matheson A, Mazza D. Recurrent vulvovaginal candidiasis: A review of guideline recommendations. Aust N Z J Obstet Gynaecol. 2017; 57:139-145.

-Xie HY, Feng D, Wei DM, Mei L, Chen H, Wang X, Fang F. Probiotics for vulvovaginal candidiasis in non-pregnant women. Cochrane Database Syst Rev. 2017; 11:CD010496

-Kaambo E, Africa C, Chambuso R, Passmore JS. Vaginal Microbiomes Associated

With Aerobic Vaginitis and Bacterial Vaginosis. Front Public Health. 2018; 26;6:78.

-Verstraelen H, Swidsinski A. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment: 2018 update. Curr Opin Infect Dis. 2019; 32:38-42.

-Onderdonk AB, Delaney ML, Fichorova RN. The Human Microbiome during Bacterial Vaginosis. Clin Microbiol Rev. 2016; 29:223-38.

-Romero Herrero D, Andreu Domingo A. Vaginosis bacteriana. Enferm Infecc Microbiol Clin. 2016; 34 Suppl 3:14-8.

-Rumyantseva TA, Bellen G, Savochkina YA, Guschin AE, Donders GG. Diagnosis of aerobic vaginitis by quantitative real-time PCR. Arch Gynecol Obstet. 2016; 294:109-22.

-Donders GGG, Bellen G, Grinceviciene S, Ruban K, Vieira-Baptista P. Aerobic vaginitis: no longer a stranger. Res Microbiol. 2017; 168:845-858.

-Fan A, Yue Y, Geng N, Zhang H, Wang Y, Xue F. Aerobic vaginitis and mixed infections: comparison of clinical and laboratory findings. Arch Gynecol Obstet. 2013; 287:329-35.

–Ortiz-de la Tabla V, Gutiérrez F. Cervicitis: Etiology, diagnosis and treatment. Enferm Infecc Microbiol Clin. 2019. pii: S0213-005X(18)30403-8.

-Marrazzo JM, Martin DH. Management of women with cervicitis. Clin Infect Dis. 2007; 44 Suppl 3:S102-10.

-Allen M. Identifying acute cervicitis in an era of less-frequent routine gynecologic examinations. JAAPA. 2018; 31:50-53.

-Jordá GB, Hanke SE, Ramos-Rincón JM, Mosmann J, Lopéz ML, Entrocassi AC, Cuffini C. Prevalencia y análisis filogenético de Chlamydia trachomatis en una población de mujeres de Posadas, Misiones. Rev Esp Quimioter. 2018; 31:21-26.

-Yeow TC, Wong WF, Sabet NS, Sulaiman S, Shahhosseini F, Tan GM, Movahed E, Looi CY, Shankar EM, Gupta R, Arulanandam BP, Hassan J, Abu Bakar S. Prevalence of plasmid-bearing and plasmid-free Chlamydia trachomatis infection among women who visited obstetrics and gynecology clinics in Malaysia. BMC Microbiol. 2016; 16:45.

-Huffam S, Chow EPF, Leeyaphan C, Fairley CK, Hocking JS, Phillips S, Tabrizi SN, Bellhouse C, Bradshaw CS, Fehler G, Garland SM, Chen MY. Chlamydia Infection Between Men and Women: A Cross-Sectional Study of Heterosexual Partnerships. Open Forum Infect Dis. 2017; 4:ofx160.

-Suzuki S, Hoshi SI, Sekizawa A, Sagara Y, Tanaka M, Kinoshita K, Kitamura T. Current status of Neisseria gonorrhoeae cervicitis in pregnant women in Japan. PLoS One. 2019; 14:e0211595.

-Lillis RA, Martin DH, Nsuami MJ. Mycoplasma genitalium Infections in Women Attending a Sexually Transmitted Disease Clinic in New Orleans. Clin Infect Dis. 2018. doi: 10.1093/cid/ciy922.

-Baumann L, Cina M, Egli-Gany D, Goutaki M, Halbeisen FS, Lohrer GR, Ali H, Scott P, Low N. Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis. Sex Transm Infect. 2018; 94255-262.

-Oliphant J, Azariah S. Cervicitis: limited clinical utility for the detection of Mycoplasma genitalium in a cross-sectional study of women attending a New Zealand sexual health clinic. Sex Health. 2013; 10:263-7.

-Chra P, Papaparaskevas J, Papadogeorgaki E, Panos G, Leontsinidis M, Arsenis G, Tsakris A. Prevalence of Mycoplasma genitalium and other sexually-transmitted pathogens among high-risk individuals in Greece. Germs. 2018; 8:12-20.

-Rosenfeld WD, Clark J. Vulvovaginitis and cervicitis. Pediatr Clin North Am. 1989; 36:489-511.

-Lusk MJ, Garden FL, Cumming RG, Rawlinson WD, Naing ZW, Konecny P. Cervicitis: a prospective observational study of empiric azithromycin treatment in women with cervicitis and non-specific cervicitis. Int J STD AIDS. 2017; 28:120-126.

-Páez-Canro C, Alzate JP, González LM, Rubio-Romero JA, Lethaby A, Gaitán HG. Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women. Cochrane Database Syst Rev. 2019;1:CD010871.

-Hadad R, Golparian D, Lagos AC, Ljungberg J, Nilsson P, Jensen JS, Fredlund H, Unemo M. Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011-2015. APMIS. 2018; 126:123-127.

-Read TRH, Fairley CK, Murray GL, Jensen JS, Danielewski J, Worthington K, Doyle M, Mokany E, Tan L, Chow EPF, Garland SM, Bradshaw CS. Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation. Clin Infect Dis. 2019; 68:554-560.

–Mitchell C, Prabhu M. Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment. Infect Dis Clin North Am. 2013; 27:793-809.

-Hoenderboom BM, van Benthem BHB, van Bergen JEAM, Dukers-Muijrers NHTM, Götz HM, Hoebe CJPA, Hogewoning AA, Land JA, van der Sande MAB, Morré SA, van den Broek IVF. Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial. Sex Transm Infect. 2019. pii: sextrans-2018-053778.

–Bugg CW, Taira T. Pelvic Inflammatory Disease: Diagnosis And Treatment In The Emergency Department. Emerg Med Pract. 2016; 18:1-24.

-Lenz JD, Dillard JP. Pathogenesis of Neisseria gonorrhoeae and the Host Defense in Ascending Infections of Human Fallopian Tube. Front Immunol. 2018; 9:2710.

–Smorgick N, As-Sanie S. Pelvic Pain in Adolescents. Semin Reprod Med. 2018; 36:116-122.

-Soper DE. Pelvic inflammatory disease. Obstet Gynecol. 2010; 116(2 Pt 1):419-28.

-Petrina MAB, Cosentino LA, Wiesenfeld HC, Darville T, Hillier SL. Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents. Anaerobe. 2019; 56:61-65.

-Latimer RL, Read TRH, Vodstrcil LA, Goller JL, Ong JJ, Fairley CK, Hocking JS, Bradshaw CS. Clinical Features and Therapeutic Response in Women Meeting Criteria for Presumptive Treatment for Pelvic Inflammatory Disease Associated With Mycoplasma genitalium. Sex Transm Dis. 2019; 46:73-79.

-Savaris RF, Fuhrich DG, Duarte RV, Franik S, Ross JDC. Antibiotic therapy for pelvic inflammatory disease: an abridged version of a Cochrane systematic review and meta-analysis of randomised controlled trials. Sex Transm Infect. 2019; 95:21-27.

-Juzbašić A, Čeović R. Chancroid, lymphogranuloma venereum, granuloma inguinale, genital herpes simplex infection, and molluscum contagiosum. Clin Dermatol. 2014; 32:290-8.

-Mungati M, Machiha A, Mugurungi O, Tshimanga M, Kilmarx PH, Nyakura J, Shambira G, Kupara V, Lewis DA, Gonese E, Tippett Barr BA, Handsfield HH, Rietmeijer CA. The Etiology of Genital Ulcer Disease and Coinfections With Chlamydia trachomatis and Neisseria gonorrhoeae in Zimbabwe: Results From the Zimbabwe STI Etiology Study. Sex Transm Dis. 2018; 45:61-68.

-Talukdar K, Chopra A, Mitra D, Mitra B. Disease Pattern among Sexually Transmitted Infection Clinic Attendees: A Hospital-Based Study. Indian J Dermatol. 2018; 63:502-505.

-Kularatne RS, Muller EE, Maseko DV, Kufa-Chakezha T, Lewis DA. Trends in the relative prevalence of genital ulcer disease pathogens and association with HIV infection in Johannesburg, South Africa, 2007-2015. PLoS One. 2018; 13:e0194125.

–Arando Lasagabaster M, Otero Guerra L. Syphilis. Enferm Infecc Microbiol Clin. 2019. pii: S0213-005X(19)30007-2.

–Patton ME, Su JR, Nelson R, Weinstock H, Centers for Disease Control and Prevention (CDC). Primary and secondary syphilis–United States, 2005-2013. MMWR Morb Mortal Wkly Rep. 2014; 63:402-6.

-Junco-Fernández A, Montgomery MC, Crowley C, Bertrand T, Marak TP, Maynard MA, Gummo C, Flanigan TP, Chan PA. Increasing Syphilis in Rhode Island: Return of an Old Foe. R I Med J. 2019; 102:50-54.

-Kidd SE, Grey JA, Torrone EA, Weinstock HS. Increased Methamphetamine, Injection Drug, and Heroin Use Among Women and Heterosexual Men with Primary and Secondary Syphilis – United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2019; 68:144-148.

-Ndeikoundam Ngangro N, Viriot D, Fournet N, Pioche C, De Barbeyrac B, Goubard A, Dupin N, Berçot B, Fouéré S, Alcaraz I, Ohayon M, Spenatto N, Vernay-Vaisse C, Referents For The Regional Offices Of The French National Public Health Agency, Pillonel J, Lot F. Bacterial sexually transmitted infections in France: recent trends and patients’ characteristics in 2016. Euro Surveill. 2019; 24. doi: 10.2807/1560-7917.

-Fustà X, Fuertes I, Lugo-Colón R, Blanco JL, Baras N, Alsina-Gibert M. Syphilis epidemics: a descriptive study of patients diagnosed in a tertiary hospital between 2011 and 2015. Med Clin (Barc). 2017; 149:536-539.

–Casanova AP, Guaita Calatrava R, Soriano Llinares L, Miguez Santiyán A, Salazar Cifre A. Vigilancia epidemiológica de la sífilis en la ciudad de Valencia. Impacto y evolución del período 2003-2014. Enferm Infecc Microbiol Clin. 2016; 34 Suppl 3:52-8.

-Gayet-Ageron A, Sednaoui P, Lautenschlager S, Ferry T, Toutous-Trellu L, Cavassini M, Yassir F, Martinez de Tejada B, Emonet S, Combescure C, Schrenzel J, Perneger T. Use of Treponema pallidum PCR in testing of ulcers for diagnosis of primary syphilis. Emerg Infect Dis. 2015; 21:127-9.

–Eyer-Silva WA, Campos JEB, Carvalho RS, Carvalho-Rangel I, Trindade-Azevedo R, Neves-Motta R. Rounded atrophic areas on the dorsum of the tongue: plaques en prairie fauchée of secondary syphilis. IDCases. 2018; 15:e00480.

-Dai S, Wang H, Lin Z. Moth-eaten Alopecia in secondary syphilis. Int J Infect Dis. 2019. pii: S1201-9712(19)30087-6.

-Walker M, Wisler R, Simmons J, Johnson A. A Case of Early Neurosyphilis. J La State Med Soc. 2017; 169:47-48.

-Munshi S, Raghunathan SK, Lindeman I, Shetty AK. Meningovascular syphilis causing recurrent stroke and diagnostic difficulties: a scourge from the past. BMJ Case Rep. 2018;2018. pii: bcr-2018-225255.

–McGill IK, Agius M. Tertiary Syphilis (General Paralysis of the Insane) and Bipolar Disorder; the role of these two disorders in the life of famous composers. Psychiatr Danub. 2018; 30(Suppl 7):563-566.

-Bharwani IL, Hershey CO. The elderly psychiatric patient with positive syphilis serology: the problem of neurosyphilis. Int J Psychiatry Med. 1998; 28:333-9.

-Zhang YQ, Huang M, Jia XY, Zou YF, Chen D. A clinical study of new cases of parenchymal neurosyphilis: has tabes dorsalis disappeared or been missed? J Neuropsychiatry Clin Neurosci. 2015; 27:e17-21.

-Fernandes B, Santos A, Carvalho L. Syphilitic Aortitis Diagnosis in Clinical Setting. Rev Port Cir Cardiotorac Vasc. 2017; 24:166.

-Drago F, Merlo G, Rebora A, Parodi A. Syphilitic aortitis and its complications in the modern era. G Ital Dermatol Venereol. 2018; 153:698-706.

-Žvirblytė R, Ereminienė E, Montvilaitė A, Jankauskas A, Ivanauskas V. Syphilitic coronary artery ostial stenosis resulting in acute myocardial infarction. Medicina (Kaunas). 2017; 53:211-216.

-Rahima S, Riyaz N, Latheef EN, Shyni PM. Squamous cell carcinoma on a syphilitic gumma: A unique presentation. Indian J Sex Transm Dis AIDS. 2015; 36:89-91.

-Asselin C, Ekindi N, Carignan A, Richard PO. Gummatous penile syphilis. IDCases. 2019;18:e00589.

–Costa-Silva M, Coutinho D, Sobrinho-Simões J, Azevedo F, Lisboa C. Cross-sectional study of Treponema pallidum PCR in diagnosis of primary and secondary syphilis. Int J Dermatol. 2018; 57:46-49.

–US Preventive Services Task Force (USPSTF), Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García FA, Gillman MW, Harper DM, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Phillips WR, Phipps MG, Pignone M Screening for Syphilis Infection in Nonpregnant Adults and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2016; 315:2321-7.

-Gambiez C, Garet C, Choquet M, Decroix V, Pluquet E, Guiheneuf R, Castelain S. Limited efficacy of nontreponemal test combined with treponemal test in the initial syphilis screening algorithm. J Med Microbiol. 2019; 68:216-220.

–Rhoads DD, Genzen JR, Bashleben CP, Faix JD, Ansari MQ. Prevalence of Traditional and Reverse-Algorithm Syphilis Screening in Laboratory Practice: A Survey of Participants in the College of American Pathologists Syphilis Serology Proficiency Testing Program. Arch Pathol Lab Med. 2017; 141:93-97.

-Yi J, Choi W, Shin S, Choi J, Kim H, Chung HJ, Moon HW, Hur M, Yun YM. Strategy for performing treponemal tests in reverse-sequence algorithms of syphilis diagnosis. Clin Biochem. 2019; 63:121-125.

-Spydell LE. Congenital Syphilis and the Prozone Phenomenon: A Case Study. Adv Neonatal Care. 2018; 18:446-450.

-Ros-Vivancos C, González-Hernández M, Navarro-Gracia JF, Sánchez-Payá J, González-Torga A, Portilla-Sogorb J. Evolución del tratamiento de la sífilis a lo largo de la historia. Rev Esp Quimioter. 2018; 31:485-492.

-Pastuszczak M, Sitko M, Bociaga-Jasik M, Kucharz J, Wojas-Pelc A. Lack of antiretroviral therapy is associated with higher risk of neurosyphilis among HIV-infected patients who remain serofast after therapy for early syphilis. Medicine (Baltimore). 2018; 97(45):e13171.

-Leeyaphan C, Punyaratabandhu P, Jiamton S, Junsuwan N, Chirachanakul P, Chanyachailert P, Omcharoen V. Predictors of serological cure after treatment in patients with early syphilis: A retrospective observational study in Thailand. Indian J Dermatol Venereol Leprol. 2019; 85:235.

–Arando Lasagabaster M, Otero Guerra L. Syphilis. Enferm Infecc Microbiol Clin. 2019. pii: S0213-005X(19)30007-2.

–Gomez GB, Kamb ML, Newman LM, Mark J, Broutet N, Hawkes SJ. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ. 2013; 91:217-26.

-Liu H, Chen N, Yu J, Tang W, He J, Xiao H, Lin S, Hu F, Feng Q, Tucker JD, Xia H, Qiu X. Syphilis-attributable adverse pregnancy outcomes in China: a retrospective cohort analysis of 1187 pregnant women with different syphilis treatment. BMC Infect Dis. 2019; 19:292.

-Slutsker JS, Hennessy RR, Schillinger JA. Factors Contributing to Congenital Syphilis Cases – New York City, 2010-2016. MMWR Morb Mortal Wkly Rep. 2018; 67:1088-1093.

-US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Kubik M, Kurth AE, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for Syphilis Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2018; 320:911-917.

-Wang Y, Wu M, Gong X, Zhao L, Zhao J, Zhu C, Gong C. Risk Factors for Congenital Syphilis Transmitted from Mother to Infant – Suzhou, China, 2011-2014. MMWR Morb Mortal Wkly Rep. 2019; 68:247-250.

-Korenromp EL, Rowley J, Alonso M, Mello MB, Wijesooriya NS Mahiané SG, Ishikawa N, Le LV, Newman-Owiredu M, Nagelkerke N, Newman L, Kamb M, Broutet N, Taylor MM. Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012. PLoS One. 2019; 14:e0211720.

–Stafford IA, Berra A, Minard CG, Fontenot V, Kopkin RH, Rodrigue E, Roitsch CM, Rac MW, Hill JB. Challenges in the Contemporary Management of Syphilis among Pregnant Women in New Orleans, LA. Infect Dis Obstet Gynecol. 2019; 2019:2613962.doi: 10.1155/2019/2613962.

-Salado-Rasmussen K. Syphilis and HIV co-infection. Epidemiology, treatment and molecular typing of Treponema pallidum. Dan Med J. 2015; 62:B5176.29.

-Cai YM, Song YJ, Liu H, Hong FC. [Factors associated with syphilis/HIV infection among men who have sex with men in Shenzhen,2011-2016]. Zhonghua Yu Fang Yi Xue Za Zhi. 2017; 51:994-1000.

-Mutagoma M, Nyirazinyoye L, Sebuhoro D, Riedel DJ, Ntaganira J. Syphilis and HIV prevalence and associated factors to their co-infection, hepatitis B and hepatitis C viruses prevalence among female sex workers in Rwanda. BMC Infect Dis. 2017; 17:525.

-Acosta LMW, Gonçalves TR, Barcellos NT. Coinfecção HIV/sífilis na gestação e transmissão vertical do HIV: um estudo a partir de dados da vigilância epidemiológica. Rev Panam Salud Publica. 2016; 40:435-442.

-Niama RF, Loukabou Bongolo NC, Bayonne Kombo ES, Yengo R, Mayengue PI, Mandingha Kosso EB, Louzolo I, Macosso L, Dzeret G, Dzabatou Babeaux ASP, Puruehnce MF, Parra HJ. Syphilis and HIV infections among pregnant women attending antenatal clinics in Republic of Congo. Pan Afr Med J. 2017; 28:8.

-Merins V, Hahn K Syphilis and neurosyphilis: HIV-coinfection and value of diagnostic parameters in cerebrospinal fluid. Eur J Med Res. 2015;20:81.

-Taylor MM, Li WY, Skinner J, Mickey T. Viral loads among young HIV-infected men with early syphilis. J Int Assoc Provid AIDS Care. 2014; 13:501-5.

-Tafesse TB, Gebru AA, Gobalee S, Belay GD, Belew MT, Ataro D, Ebrahim BA, Shebeshi GM, Yimam Y. Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donors. Hum Antibodies. 2017; 25:39-55.

-Lawrence D, Cresswell F, Whetham J, Fisher M. Syphilis treatment in the presence of HIV: the debate goes on. Curr Opin Infect Dis. 2015; 28:44-52.

-Trees DL, Morse SA. Chancroid and Haemophilus ducreyi: an update. Clin Microbiol Rev. 1995; 8:357-75.

-Steen R. Eradicating chancroid. Bull World Health Organ. 2001; 79:818-26.

-Agharbi FZ. Chancre mou. Pan Afr Med J. 2019; 33:185.

-Lautenschlager S, Kemp M, Christensen J, Mayans M, Moi H. 2017 European guideline for the management of chancroid. International Journal of STD & AIDS. 2017; 28: 324-329.

-Romero L, Huerfano C, Grillo-Ardila CF. Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults. Cochrane Database Syst Rev. 2017 Dec 11; 12:CD012492.

-O’Byrne P, MacPherson P, DeLaplante S, Metz G, Bourgault A. Approach to lymphogranuloma venereum. Can Fam Physician. 2016; 62:554-8.

-Dal Conte I, Mistrangelo M, Cariti C, Chiriotto M, Lucchini A, Vigna M, Morino M, Di Perri G. Lymphogranuloma venereum: an old, forgotten re-emerging systemic disease. Panminerva Med. 2014; 56:73-83.

-de Vrieze NH, de Vries HJ. Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review. Expert Rev Anti Infect Ther. 2014; 12:697-704.

-de Vrieze NHN, Versteeg B, Bruisten SM, van Rooijen MS, van der Helm JJ, de Vries HJC. Low Prevalence of Urethral Lymphogranuloma Venereum Infections Among Men Who Have Sex With Men: A Prospective Observational Study, Sexually Transmitted Infection Clinic in Amsterdam, the Netherlands. Sex Transm Dis. 2017; 44:547-550.

-Saxon C, Hughes G, Ison C; UK LGV Case-Finding Group. Asymptomatic Lymphogranuloma Venereum in Men who Have Sex with Men, United Kingdom. Emerg Infect Dis. 2016; 22:112-116.

-Isaksson J, Carlsson O, Airell Å, Strömdahl S, Bratt G, Herrmann B. Lymphogranuloma venereum rates increased and Chlamydia trachomatis genotypes changed among men who have sex with men in Sweden 2004-2016. J Med Microbiol. 2017; 66:1684-1687.

Desclaux A, Touati A, Neau D, Laurier-Nadalié C, Bébéar C, de Barbeyrac B, Cazanave C. Extra-rectal lymphogranuloma venereum in France: a clinical and molecular study. Sex Transm Infect. 2018; 94:3-8.

-Totten S, MacLean R, Payne E, Severini A. Chlamydia and lymphogranuloma venereum in Canada: 2003-2012 Summary Report. Can Commun Dis Rep. 2015; 41:20-25.

-European Centre for Disease Prevention and Control. Lymphogranuloma venereum. In: ECDC. Annual epidemiological report for 2016. Stockholm: ECDC; 2018, visitado el 20 de octubre de 2018.

-Diaz A, Ruiz-Algueró M, Hernando V. Lymphogranuloma venereum in Spain, 2005-2015: A literature review. Med Clin (Barc). 2018; 151:412-417.

-de Vries H, de Barbeyrac B, de Vrieze N, Viset J, White J, Vall-Mayans, Unemo M. 2019 European guideline on the management of lymphogranuloma venereum. Journal of the European Academy of Dermatology and Venereology. 2019. Ahead of print.

-Chiu S, Argaez C. Ivermectin for Parasitic Skin Infections of Scabies: A Review of Comparative Effectiveness, Cost-Effectiveness, and Guidelines [Internet]. Clinical Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 May. CADTH Rapid Response Reports

-Executive Committee of Guideline for the Diagnosis and Treatment of Scabies. Collaborators: Ishii N, Asai T, Asahina A, Ishiko A, Imamura H, Kato T, Kanazawa N, Kubota Y, Kurosu H, Kono T, Komoda M, Sekine M, Tanaka M, Taniguchi H, Tsunemi Y, Natsuaki M, Hirota T, Makigami K, Matsuda T, Yoshizumi J, Yotsu R, Wada Y. Guideline for the diagnosis and treatment of scabies in Japan (third edition): Executive Committee of Guideline for the Diagnosis and Treatment of Scabies. J Dermatol. 2017; 44:991-1014.

-Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. N Engl J Med 2010; 362:717.

-Monsel G, Chosidow O. Management of scabies. Skin Therapy Lett. 2012; 17:1-4.

-Veraldi S, Pontini P, Nazzaro G. Phthirus pubis Infestation of the Scalp: A Case Report and Review of The Literature. Korean J Parasitol. 2018; 56:487-489.